Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 51

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 51
---
.

(14) Consists of (i) 1,130 shares of common stock held directly by Dr. Dalal, (ii) the securities listed in footnote (5) above, and (iii) 117,727 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025.

(15) Consists of 110,209 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025.

(16) Consists of 88,591 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025.

<div align='center'>31</div>

(17) Consists of 133,999 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025.

(18) Consists of 109,146 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025.

(19) Consists of (i) 1,250,000 shares of common stock held indirectly by WZCUBE LLC, which were purchased in the PIPE Financing, and (ii) 8,498 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025. Dr. Zhao is the manager of WZCUBE LLC and exercises investment and voting power over the shares held. Dr. Zhao disclaims beneficial ownership of the shares held by WZCUBE LLC, except to the extent of his pecuniary interest therein.

(20) Consists of an aggregate of (i) 20,738,559 shares of common stock and/or shares of common stock subject to Pre-Funded Warrants and (ii) 2,595,685 shares issuable upon the exercise of stock options within 60 days of April 17, 2025 held by our current executive officers and directors as a group.

<div align='center'>32</div>

### CERTAIN RELATIONSHIPS AND RELATED-PERSON TRANSACTIONS
The following is a description of each transaction since January 1, 2023, and each currently proposed tr ansaction, in which we were a party and in which:

• the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years;